• Explore /
  • Poster
  • / Efficacy and safety of olaparib in patients with tumors harboring alterations in homologous recombination repair pathway associated genes: Results from the Drug Rediscovery Protocol.

Efficacy and safety of olaparib in patients with tumors harboring alterations in homologous recombination repair pathway associated genes: Results from the Drug Rediscovery Protocol.

Abstract Poster

Authors

null

Ilse Anna Catharina Spiekman

Department of Medical Oncology, Erasmus Medical Cancer Institute, Rotterdam, Netherlands

Ilse Anna Catharina Spiekman , Niven Mehra , Laurien Joanna Zeverijn , Birgit Geurts , Karlijn Verkerk , Soemeya Fooziye Haj Mohammad , Vincent van der Noort , Paul Roepman , Wendy W.J. de Leng , Anne M.L. Jansen , Addy C.M. van de Luijtgaarden , Theo Van Voorthuizen , Tineke E. Buffart , Hans Gelderblom , Emile E. Voest , Henk M.W. Verheul

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Small Molecules

Clinical Trial Registration Number

NCT02925234

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 3116)

DOI

10.1200/JCO.2024.42.16_suppl.3116

Abstract #

3116

Poster Bd #

261

Abstract Disclosures

Similar Posters

First Author: Neal D. Shore

First Author: Qiuxiang Ou

First Author: Tanya Jindal

First Author: Vivek Narayan